CSF1 and breast cancer: Genetic deletion of CSF-1 resulted in reduction of mammary TAMs and in lower incidence of lung metastasis in in vivo mammary tumor mouse models (153), deletion of ETS2 in macrophages resulted in reduced metastatic tumor burden (153) and its elevated expression has been correlated with human breast cancer (154).